Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of RP103 (Procysbi) in Cystinosis
NCT01197378Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2010
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cysteamine in cystinosis, sponsored by Amgen. Started Aug 2010; status: completed.
02
Drugs
cysteamine
03
Conditions
cystinosis
Beyond the preview
Go deeper on NCT01197378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197378.